Ticker

No recent analyst price targets found for MRNY.

Latest News for MRNY

3 ETFs Catapulting Beyond the S&P to Start the Year

About a month into the new year, exchange-traded funds (ETFs) are beginning to build up enough of a performance record for 2026 to potentially differentiate themselves from the broader market. The funds with the best track record in 2026 may surprise some investors.

MarketBeat • Jan 29, 2026
MRNY: Jumping On Big Moderna Move

YieldMax MRNA Option Income Strategy ETF has rebounded sharply from historic lows, driven by positive catalysts in underlying Moderna. MRNY's distributions have increased alongside MRNA's share price resurgence, demonstrating the ETF's alignment with its underlying performance. Recent MRNA catalysts include partnership rumors, better-than-expected Q3 2025 revenue, EMA COVID shot approval, and promising cancer…

Seeking Alpha • Jan 22, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MRNY.

No Senate trades found for MRNY.

No House trades found for MRNY.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top